TY - JOUR
T1 - Propranolol reduces cardiac index but does not adversely affect peripheral perfusion in severely burned children
AU - Wurzer, Paul
AU - Branski, Ludwik K.
AU - Clayton, Robert P.
AU - Hundeshagen, Gabriel
AU - Forbes, Abigail A.
AU - Voigt, Charles
AU - Andersen, Clark R.
AU - Kamolz, Lars P.
AU - Woodson, Lee C
AU - Suman, Oscar E.
AU - Finnerty, Celeste C.
AU - Herndon, David
N1 - Funding Information:
This study was supported by the National Institutes of Health (P50 GM060338, UL1TR000071, T32 GM008256, RO1-GM056687, RO1-112936, R01-HD049471), the Shriners Hospitals for Children (71006, 71008, 71009, 80100, 84080, 84291), and Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1 TR001439) from the National Center for Advancing Translational Sciences, National Institutes of Health.
Publisher Copyright:
Copyright © 2016 by the Shock Society.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Purpose: The aim of this study was to quantify the effect of propranolol on hemodynamic parameters assessed using the PiCCO system in burned children. Methods: We analyzed hemodynamic data from patients who were randomized to receive either propranolol (4 mg/kg/day) or placebo (control), which was initiated as a prospective randomized controlled trial. Endpoints were cardiac index (CI), percent predicted heart rate (%HR), mean arterial pressure (MAP), percent predicted stroke volume (%SV), rate pressure product (RPP), cardiac work (CW), systemic vascular resistance index (SVRI), extravascular lung water index (EVLWI), arterial blood gases, events of lactic acidosis, and mortality. Mixed multiple linear regressions were applied, and a 95% level of confidence was assumed. Results: One hundred twenty-one burned children (control: n=62, propranolol: n=59) were analyzed. Groups were comparable in demographics, EVLWI, SVRI, %SV, arterial blood gases, Denver 2 postinjury organ failure score, incidence of lactic acidosis, or mortality. Percent predicted HR, MAP, CI, CW, and RPP were significantly reduced in the propranolol-treated group (P<0.01). Conclusions: Propranolol significantly reduces cardiogenic stress by reducing CI and MAP in children with severe burn injury. However, peripheral oxygen delivery was not reduced and events of lactic acidosis as well as organ dysfunction was not higher in propranolol treated patients.
AB - Purpose: The aim of this study was to quantify the effect of propranolol on hemodynamic parameters assessed using the PiCCO system in burned children. Methods: We analyzed hemodynamic data from patients who were randomized to receive either propranolol (4 mg/kg/day) or placebo (control), which was initiated as a prospective randomized controlled trial. Endpoints were cardiac index (CI), percent predicted heart rate (%HR), mean arterial pressure (MAP), percent predicted stroke volume (%SV), rate pressure product (RPP), cardiac work (CW), systemic vascular resistance index (SVRI), extravascular lung water index (EVLWI), arterial blood gases, events of lactic acidosis, and mortality. Mixed multiple linear regressions were applied, and a 95% level of confidence was assumed. Results: One hundred twenty-one burned children (control: n=62, propranolol: n=59) were analyzed. Groups were comparable in demographics, EVLWI, SVRI, %SV, arterial blood gases, Denver 2 postinjury organ failure score, incidence of lactic acidosis, or mortality. Percent predicted HR, MAP, CI, CW, and RPP were significantly reduced in the propranolol-treated group (P<0.01). Conclusions: Propranolol significantly reduces cardiogenic stress by reducing CI and MAP in children with severe burn injury. However, peripheral oxygen delivery was not reduced and events of lactic acidosis as well as organ dysfunction was not higher in propranolol treated patients.
KW - Burns
KW - Cardiac index
KW - Cardiac output
KW - Hypermetabolism
KW - Transpulmonary thermodilution
UR - http://www.scopus.com/inward/record.url?scp=84977071804&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84977071804&partnerID=8YFLogxK
U2 - 10.1097/SHK.0000000000000671
DO - 10.1097/SHK.0000000000000671
M3 - Article
C2 - 27380530
AN - SCOPUS:84977071804
SN - 1073-2322
VL - 46
SP - 486
EP - 491
JO - Shock
JF - Shock
IS - 5
ER -